USPTO serial 79361531
GENTLEMACS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 5, 2023
- Examiner
- LEIPZIG, MARC J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENTLEMACS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial, scientific and diagnostic purposes, other than for medical or veterinary use, namely, biological tissue cultures, diagnostic preparations for scientific use, enzymes and lysing reagent for tissue fragmentation; chemical preparations for use in separation processes for biological materials; reagents for scientific research and use, namely, reagents for cell separation or cell fragmentation, labeling reagents, and reagents for the preparation of media, all for commercial and scientific purposes and for the use in medical research laboratories; chemical reagents, not for medical or veterinary purposes, for the fragmentation, processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials; chemical reagents with magnetic beads; chemical antibody reagents, other than for medical or veterinary purposes; buffer solutions and chemical reagents for use with laboratory instruments, especially fragmentation or separation instruments, chemical analysis instruments, reactors and imaging instruments; reagents other than for medical or veterinary purposes, for processing of biological material, especially tissue, bone marrow, cells, blood and its components; diagnostic reagents and preparations for scientific purposes and for use in medical research laboratories; cell culture media for in-vivo imaging, all for scientific purposes; chemical reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry | ACTIVE | — |
| 009 | Scientific, optical and measuring apparatus and instruments, namely, laboratory apparatus and instruments for the fragmentation, separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images; data processing equipment; downloadable computer software, for use in operating and controlling equipment in connection with the separation, analysis, processing and cultivation of biological material; scientific, laboratory apparatus being electrical and electronic apparatus and instruments for conducting enzymatic reactions; laboratory equipment, in particular cytometer for measuring physical and chemical properties of cells and other particles in suspensions; laboratory equipment being tissue fragmentation machines for research use, namely, for use in pathology; laboratory equipment being tissue fragmentation vessels for research use; laboratory equipment, being sacks, bags, sheets, tubes and connectors for scientific or biotechnological purposes, in particular for tissue fragmentation for use in cryopreservation; laboratory apparatus and instruments for scientific purposes, namely, tissue fragmentation equipment | ACTIVE | — |
| 010 | Medical apparatus for magnetic cell separation for medical purposes; blood tubing sets, sold empty, for medical purposes; medical apparatus being columns for analysis for medical purposes; sacks, bags, sheets, tubes and connectors for medical purposes, in particular for tissue and blood collection for cryopreservation; tissue fragmentation machines for medical use, namely, machines for use in pathology; tissue fragmentation vessels being test tubes for medical use; medical apparatus and instruments, namely, tissue fragmentation equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named GENTLEMACS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 6, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 15, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 7, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 7, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 7, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 1, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 6, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |